Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models

References

• FribergSNyströmAMNanotechnology in the war against cancer: new arms against an old enemy – a clinical viewFuture Oncol201511131961197526161930
   PubMedGoogle Scholar
• BarenholzYCDoxil® – the first FDA-approved nano-drug: lessons learnedJ Control Release2012160211713422484195
   PubMed Web of Science ®Google Scholar
• DawidczykCMKimCParkJHState-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicinesJ Control Release201418713314424874289
   PubMed Web of Science ®Google Scholar
• LooYGrigsbyCLYamanakaYJComparative study of nanoparticle-mediated transfection in different GI epithelium co-culture modelsJ Control Release20121601485622326811
   PubMedGoogle Scholar
• MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res19864612 Pt 1638763922946403
   PubMed Web of Science ®Google Scholar
• SaLTAlbernaz MdeSPatricioBFBiodistribution of nanoparticles: initial considerationsJ Pharm Biomed Anal20127060260422742922
   PubMed Web of Science ®Google Scholar
• HuCMZhangLTherapeutic nanoparticles to combat cancer drug resistanceCurr Drug Metab200910883684120214578
   PubMed Web of Science ®Google Scholar
• BuseJEl-AneedAProperties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advancesNanomed (Lond)20105812371260
   Google Scholar
• BeiDMengJYouanBBEngineering nanomedicines for improved melanoma therapy: progress and promisesNanomed (Lond)20105913851399
   PubMed Web of Science ®Google Scholar
• National Cancer InstituteSEER stat fact sheets: melanoma of the skin2016 Available from: http://seer.cancer.gov/statfacts/html/melan.htmlAccessed August 12, 2016
   Google Scholar
• WeideBFallerCBüttnerPPrognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosisPLoS One201384e6313723638183
   PubMed Web of Science ®Google Scholar
• BowenGMBowenARFlorellSRLentigo maligna: one size does not fit allArch Dermatol2011147101211121322006139
   PubMedGoogle Scholar
• KlaaseJMKroonBBvan GeelANEggermontAMFranklinHRSystemic leakage during isolated limb perfusion for melanomaBr J Surg1993809112411268402109
   PubMedGoogle Scholar
• Di GiacomoAMDanielliRCalabroLIpilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy)Cancer Immunol Immunother201160446747721170646
   PubMed Web of Science ®Google Scholar
• EggermontAMKirkwoodJMRe-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?Eur J Cancer200440121825183615288283
   PubMed Web of Science ®Google Scholar
• SoengasMSLoweSWApoptosis and melanoma chemoresistanceOncogene200322203138315112789290
   PubMed Web of Science ®Google Scholar
• FernbergJOLewensohnRSkogSCell cycle arrest and DNA damage after melphalan treatment of the human myeloma cell line RPMI 8226Eur J Haematol19914731611671915798
   PubMedGoogle Scholar
• MaDQRajewskiRAStellaVJNew injectable melphalan formulations utilizing (SBE)(7m)-β-CD or HP-β-CDInt J Pharm1999189222723410536251
   PubMedGoogle Scholar
• GeraSMuschEOsterheldHLoosURelevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myelomaCancer Chemother Pharmacol198923276802910515
   PubMed Web of Science ®Google Scholar
• MichelDChitandaJMBaloghRDesign and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanomaEur J Pharm Biopharm201281354855622531300
   PubMed Web of Science ®Google Scholar
• PoorghorbanMDasUAlaidiOCharacterization of the host-guest complex of a curcumin analog with beta-cyclodextrin and beta-cyclodextrin-gemini surfactant and evaluation of its anticancer activityInt J Nanomed201510503515
   PubMedGoogle Scholar
• PoorghorbanMKaroyoAHGrochulskiPVerrallREWilsonLDBadeaIA 1H NMR study of host/guest supramolecular complexes of a curcumin analogue with beta-cyclodextrin and a beta-cyclodextrin-conjugated gemini surfactantMol Pharm20151282993300626083126
   PubMedGoogle Scholar
• OdotJAlbertPCarlierATarpinMDevyJMadouletCIn vitro and in vivo anti-tumoral effect of curcumin against melanoma cellsInt J Cancer2004111338138715221965
   PubMed Web of Science ®Google Scholar
• McGaryECHeimbergerAMillsLA fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivoClin Cancer Res20039176560656614695161
   PubMedGoogle Scholar
• GrattonSERoppPAPohlhausPDThe effect of particle design on cellular internalization pathwaysProc Nat Acad Sci U S A2008105331161311618
   PubMed Web of Science ®Google Scholar
• PatelNRAryasomayajulaBAbouzeidAHTorchilinVPCancer cell spheroids for screening of chemotherapeutics and drug-delivery systemsTher Deliv20156450952025996047
   PubMed Web of Science ®Google Scholar
• LeeCKWangSHuangXRyderJLiuBHDAC inhibition synergistically enhances alkylator-induced DNA damage responses and apoptosis in multiple myeloma cellsCancer Lett2010296223324020447761
   PubMed Web of Science ®Google Scholar
• BoseSTuunainenIParryMMedinaOPManciniGKinnunenPKBinding of cationic liposomes to apoptotic cellsAnal Biochem2004331238539415265746
   PubMedGoogle Scholar
• MailänderVLandfesterKInteraction of nanoparticles with cellsBiomacromolecules20091092379240019637907
   PubMed Web of Science ®Google Scholar
• DudduSPVakilynejadMJamaliFGrantDJStereoselective dissolution of propranolol hydrochloride from hydroxypropyl methylcellulose matricesPharm Res19931011164816538290480
   PubMed Web of Science ®Google Scholar
• DewanMBhowmickBSarkarGEffect of methyl cellulose on gelation behavior and drug release from poloxamer based ophthalmic formulationsInt J Biol Macromol20157270671025256549
   PubMed Web of Science ®Google Scholar
• MuankaewCJansookPStefánssonELoftssonTEffect of γ-cyclodextrin on solubilization and complexation of irbesartan: influence of pH and excipientsInt J Pharm20144741–2809025128698
   PubMedGoogle Scholar
• KuznetsovaNRSevrinCLespineuxDHemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayerJ Control Release2012160239440022210161
   PubMed Web of Science ®Google Scholar
• DongCBadeaIPoorghorbanMVerrallRFoldvariMImpact of phospholipids on plasmid packaging and toxicity of gemini nanoparticlesJ Mater Chem B Mater Biol Med20153458806882226693021
   PubMedGoogle Scholar
• SzakácsGPatersonJKLudwigJABooth-GentheCGottesmanMMTargeting multidrug resistance in cancerNat Rev Drug Discov20065321923416518375
   PubMed Web of Science ®Google Scholar
• DilnawazFSahooSKEnhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid modelEur J Pharm Biopharm2013853 Pt A45246223891772
   PubMed Web of Science ®Google Scholar
• ScaranoWde SouzaPStenzelMHDual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancerBiomater Sci20153116317426214199
   PubMed Web of Science ®Google Scholar
• ValettiSMaioneFMuraSPeptide-functionalized nanoparticles for selective targeting of pancreatic tumorJ Control Release2014192293924984010
   PubMed Web of Science ®Google Scholar
• WangHZhaoYGongJLow-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancerJ Control Release2014192475625003794
   PubMed Web of Science ®Google Scholar
• CarvalhoMRLimaDReisRLCorreloVMOliveiraJMEvaluating biomaterial- and microfluidic-based 3D tumor modelsTrends Biotechnol2015331166767826603572
   PubMed Web of Science ®Google Scholar
• LoeberRMichaelsonEFangQCampbellCPeggAETretyakovaNCross-linking of the DNA repair protein Omicron6-alkylguanine DNA alkyltransferase to DNA in the presence of antitumor nitrogen mustardsChem Res Toxicol200821478779518324787
   PubMed Web of Science ®Google Scholar
• JangiSMDíaz-PérezJLOchoa-LizarraldeBH1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cellsCarcinogenesis20062791787179616569656
   PubMed Web of Science ®Google Scholar
• GalluzziLVitaleIVacchelliEKroemerGCell death signaling and anticancer therapyFrontiers Oncol201115
   Google Scholar
• GaoZZhangLSunYNanotechnology applied to overcome tumor drug resistanceJ Control Release20121621455522698943
   PubMed Web of Science ®Google Scholar
• HuXZhangZUnderstanding the genetic mechanisms of cancer drug resistance using genomic approachesTrends Genet201632212713726689126
   PubMed Web of Science ®Google Scholar
• SahaSAdhikaryABhattacharyyaPDasTSaGDeath by design: where curcumin sensitizes drug-resistant tumoursAnticancer Res20123272567258422753715
   PubMed Web of Science ®Google Scholar
• ChenKGValenciaJCGilletJPHearingVJGottesmanMMInvolvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanomaPigm Cell Melanoma Res2009226740749
   Google Scholar
• WoutersJStasMGovaereOVan den EyndeKVankelecomHvan den OordJJGene expression changes in melanoma metastases in response to high-dose chemotherapy during isolated limb perfusionPigm Cell Melanoma Res2012254454465
   PubMed Web of Science ®Google Scholar